Frontlight ResearchEarly access
Trial site
Advanced Memory Research Institute of New Jersey
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease9 trials
- Frontotemporal dementia1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- AriBio Co., Ltd.1 trial
- Bristol-Myers Squibb1 trial
- Eisai Inc.1 trial
- Neurim Pharmaceuticals Ltd.1 trial
Running trials
Recruiting
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026